| Website | diagnoplex.com |
| Category | BioTech |
| Phone | +41 21 989 20 00 |
| Employees | |
| Founded | 2005 |
| Description | molecular cancer diagnostics |
| Series A, 12/08 Novartis Venture Funds NeoMed | $8.3M |
Diagnoplex has been founded in 2005 supported by seed financing fron the Novartis Forschungsstiftung, Swiss Confederation CTI project, Canton de Vaud FIT and the Gebert Rüf Stiftung. The company has performed a 140 patient prospective pilot study demonstrating technical and clinical feasibility of its colorectal cancer screening test COLOX as well as its high sensitivity and specificity.
